SEARCH

SEARCH BY CITATION

References

  • 1
    Brundage JF, Shanks GD. What really happened during the 1918 influenza pandemic? The importance of bacterial secondary infections. J Infect Dis2007; 196:17171718.
  • 2
    Chien YW, Klugman KP, Morens DM. . Efficacy of whole-cell killed bacterial vaccines in preventing pneumonia and death during the 1918 influenza pandemic. J Infect Dis1918; 202:16391648.
  • 3
    Chowell G, Bertozzi SM, Colchero MA et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med2009; 361:674679.
  • 4
    Morens DM, Taubenberger JK, Fauci AS. The persistent legacy of the 1918 influenza virus. N Engl J Med2009; 361:225229.
  • 5
    Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis2008; 198:962970.
  • 6
    Lessler J, Reich NG, Cummings DA, Nair HP, Jordan HT, Thompson N. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med2009; 361:26282636.
  • 7
    Shieh WJ, Blau DM, Denison AM et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol2010; 177:166175.
  • 8
    Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med2009; 361:2493.
  • 9
    Cunha BA, Syed U, Strollo S. Swine influenza (H1N1) pneumonia in hospitalized adults: chest film findings. Heart Lung2011; 40:253256.
  • 10
    Dandona P, Nix D, Wilson MF et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab1994; 79:16051608.
  • 11
    Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res2000; 49(Suppl 1):S57S61.
  • 12
    Ahn S, Kim WY, Kim SH et al. Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia. Influenza Other Respi Viruses2011; 5:398403.
  • 13
    Cuquemelle E, Soulis F, Villers D et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre studyIntensive Care Med2011; 37:796800.
  • 14
    Guervilly C, Coisel Y, Botelho-Nevers E et al. Significance of high levels of procalcitonin in patients with influenza A (H1N1) pneumonia. J Infect2010; 61:355358.
  • 15
    Han SS, Kim SH, Kim WJ, Lee SJ, Ryu SW, Cheon MJ. Diagnostic role of C-reactive protein, procalcitonin and lipopolysaccharide-binding protein in discriminating bacterial-community acquired pneumonia from 2009 H1N1 influenza A infection. Tuberc Respir Dis2011; 70:490497.
  • 16
    Ingram PR, Inglis T, Moxon D, Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med2010; 36:528532.
  • 17
    Song JY, Cheong HJ, Heo JY et al. Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia. Influenza Other Respi Viruses2011; 5:e535e543.
  • 18
    Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med2008; 149:889897.
  • 19
    Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol2006; 187:271281.
  • 20
    Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol2006; 6:9.
  • 21
    Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ2003; 326:4144.
  • 22
    Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol2005; 58:982990.
  • 23
    Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med2004; 140:189202.
  • 24
    Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med2002; 21:15251537.
  • 25
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials1986; 7:177188.
  • 26
    Song F, Khan KS, Dinnes J, Sutton AJ. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol2002; 31:8895.
  • 27
    Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet2006; 368:22112218.
  • 28
    Schuetz P, Christ-Crain M, Thomann R et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA2009; 302:10591066.
  • 29
    Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet2004; 363:600607.